Dewael RX SRL
Dewael RX reported total assets of 505,917 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jun 2026).
The score of Dewael RX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets +73 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dewael RX's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 226,438 € | ||||
| Equity | 19,003 € | ||||
| Cash | 323,290 € | ||||
| EBITDA | 324,439 € | ||||
| Total assets | 505,917 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
Dewael RX's financial analysis
- Solvency3.8%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dewael RX
Dewael RX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0635.804.118
- VAT number
- BE0635804118
- Peppol
- Registered · 0208:0635804118 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Aug 2015
- Registered office
- 5340 Gesves
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Dewael RX (SRL) has been based in Gesves since 2015, active in: medical specialists activities. For 2025, it reports a net profit of 226,438 € and equity of 19,003 €; its revenue is not published. Its solvency stands at 3.8%, below the median of its sector (65.0%).
Companies similar to Dewael RX
Companies in the same business, of comparable size and area, outside its group.
- DR. Oris Bart Medical specialists activities Heist-op-den-Berg · balance sheet 505,807 €
- Dr. V. Janssens Medical specialists activities Schoten · balance sheet 505,676 €
- Xhaët Nathalie Medical specialists activities Nivelles · balance sheet 506,214 €
- Dr. Caroline Barthels, Radiologie Medical specialists activities Hasselt · balance sheet 505,144 €
- DR. ELS NOE Medical specialists activities Antwerp · balance sheet 504,737 €
- Pr. Frédéric SCHUIND Medical specialists activities Anderlecht · balance sheet 504,597 €
- Cabinet Médical du Docteur Céline DEVILLERS Medical specialists activities Trooz · balance sheet 504,533 €
- DR. Sofie Depuydt, Heelkunde Medical specialists activities Ostend · balance sheet 507,436 €
Frequently asked questions about Dewael RX
What is the revenue of Dewael RX?
Dewael RX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dewael RX?
In Belgium, the VAT number is the company number prefixed with BE: BE0635804118 for Dewael RX, if the company is VAT-registered. Its company number (CBE) is 0635.804.118.
Where is the registered office of Dewael RX?
According to the CBE register, the registered office of Dewael RX is in 5340 Gesves.
What is the equity of Dewael RX?
At the close of the 2025 financial year, the equity of Dewael RX amounts to 19,003 €, a solvency of 3.8% of total assets.
Who manages Dewael RX?
The register lists 1 active mandates at Dewael RX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dewael RX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →